ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

DAVID RATH M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,813Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 2061

$869K Total Retail Price of All Prescriptions

Rank: 192 out of 2061

617 Patients Receiving at Least One Drug in Part D
29%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 617 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 617 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

5% of this provider’s 6,090 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LISINOPRIL 1,143 420 1 2
ALPRAZOLAM 1,008 224 2 85
SIMVASTATIN 781 260 3 1
ZOLPIDEM TARTRATE 763 114 4 23
OMEPRAZOLE 729 207 5 5
PROAIR HFA 703 123 6 40
GABAPENTIN 687 171 7 15
IBUPROFEN 513 82 8 90
CITALOPRAM HBR 500 95 9 20
FUROSEMIDE 433 188 10 6
METFORMIN HCL 431 143 11 9
AMLODIPINE BESYLATE 430 142 12 4
PROMETHAZINE HCL 408 112 R 13 119
TIZANIDINE HCL 396 64 14 137
LEVOTHYROXINE SODIUM 393 159 15 3
TRAZODONE HCL 356 73 16 39
DIAZEPAM 337 93 10 17 270
CYCLOBENZAPRINE HCL 335 75 R 18 78
NEXIUM 301 56 19 26
TRIAMTERENE-HCTZ 295 75 20 38
POTASSIUM CHLORIDE 265 147 21 16
RANITIDINE HCL 252 51 22 53
METHOCARBAMOL 243 47 R 23 203
CLONAZEPAM 226 55 24 241
NAPROXEN 226 43 24 110
METOPROLOL TARTRATE 226 63 24 7
AZITHROMYCIN 220 70 27 34
HYDROCODONE-ACETAMINOPHEN 216 93 S3 28 10
CYMBALTA 200 0 29 59
CARVEDILOL 192 91 30 22
VENTOLIN HFA 176 50 31 234
LISINOPRIL-HYDROCHLOROTHIAZIDE 172 40 32 27
ATORVASTATIN CALCIUM 172 61 32 8
ATENOLOL 167 40 34 13
JANUVIA 163 47 35 51
OXYCODONE HCL 158 46 S2 36 82
CLOPIDOGREL 150 50 37 29
SPIRIVA 142 46 38 63
HYDROCHLOROTHIAZIDE 127 94 39 12
MELOXICAM 127 27 39 44
SUBOXONE 125 0 41 242
SERTRALINE HCL 125 38 41 21
LORAZEPAM 123 31 43 96
GLIMEPIRIDE 118 44 44 33
LOVASTATIN 113 49 45 35
PAROXETINE HCL 106 17 46 61
FLUTICASONE PROPIONATE 102 0 47 43
OXYCODONE HCL-ACETAMINOPHEN 95 17 S2 48 114
FLUOXETINE HCL 95 0 48 73
MIRTAZAPINE 93 22 50 46
DIOVAN 91 22 51 41
AMITRIPTYLINE HCL 88 22 R 52 89
FENOFIBRATE 87 15 53 65
GLIPIZIDE 86 38 54 55
BACLOFEN 85 0 55 123
ROPINIROLE HCL 84 19 56 92
PLAVIX 82 27 57 49
CLOTRIMAZOLE-BETAMETHASONE 80 32 58 173
CIPROFLOXACIN HCL 79 22 59 54
SEROQUEL XR 79 11 59 282
LANSOPRAZOLE 77 22 61 139
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 14 61 87
SYMBICORT 76 12 63 158
SINGULAIR 74 14 64 88
OXYCODONE-ACETAMINOPHEN 74 51 S2 64 36
FAMOTIDINE 71 26 66 67
ZETIA 71 0 66 68
LANTUS SOLOSTAR 69 0 68 76
KLOR-CON M20 69 43 68 47
WARFARIN SODIUM 68 24 70 11
SULINDAC 68 0 70 330
TEMAZEPAM 66 19 72 265
CLONIDINE HCL 65 18 73 52
ALLOPURINOL 63 27 74 28
CARISOPRODOL 63 0 R 74 156
QVAR 63 11 74 286
LIDODERM 63 0 74 106
VENLAFAXINE HCL ER 60 0 78 109
LUNESTA 59 0 79 401
DIVALPROEX SODIUM 59 0 79 74
DICYCLOMINE HCL 57 0 81 207
BUPROPION HCL SR 57 0 81 209
OXYBUTYNIN CHLORIDE ER 57 32 81 80
DICLOFENAC SODIUM 54 13 84 147
DIOVAN HCT 51 16 85 99
ENDOCET 50 24 S2 86 221
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.